IEX Stock Recent News

IDEX Biometrics ASA held an extraordinary general meeting on 11 April 2025. 268,077,252 million shares or 32.24 % of the capital was represented at the meeting.

Idex (IEX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

IEX benefits from strength in its Fluid & Metering Technologies segment, acquisitions and shareholder-friendly policies. However, rising costs and expenses are concerning.

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS STOCK EXCHANGE ANNOUNCEMENT.

Reference is made to the announcement by IDEX Biometrics ASA on 18 March 2025 regarding the results of the exercise of Warrants A. A total of 17,258 Warrants A were exercised, resulting in an aggregate subscription for 17,258 new shares, each Warrant A having an exercise price of NOK 0.15.

IDEX Biometrics ASA (“IDEX” or “Company”) released its preliminary financial statements for 2024 on 27 February 2025. Subsequently, on 11 March 2025, the Company announced its revised business strategy plan. The Company has reviewed its assets and business in view of this strategy. Certain equipment items have been written down and an obsolescence provision has been recognised on inventory, and other, minor adjustments have been made. The total effect for the IDEX Biometrics group on the consolidated result for 2024 and the consolidated net equity as of 31 December 2024 amounted to an increased loss of USD 1.6 million and lower equity by the same amount. This will be reflected in the annual financial statements for 2024 to be issued on 30 April 2025.

IDEX Biometrics ASA will hold an extraordinary general meeting (“EGM”) on Friday 11 April 2025 at 12.00 CET as an online meeting.  Reference is made to the announcement by IDEX Biometrics ASA (the "Company") on 11 March 2025 regarding the loan financing of NOK 30 million secured, proposed debt conversion, and amendment of Convertible Bond.

Issuer name: IDEX Biometrics ASA Ex. date: 11 March 2025 Type of corporate action: Possible subsequent offering (repair issue) This information is published in accordance with the requirements of the Continuing Obligations.

Oslo, 11 March 2025 Reference is made to the stock exchange notice from IDEX Biometrics ASA ("IDEX" or the "Company") on 11 March 2025 regarding irrevocable undertakings from certain existing shareholders for a total loan amount of NOK 30 million (“Loans”), and a possible subsequent offering, raising up to NOK 6 million, at the same subscription price as in the debt conversion related to the Loans (the "Subsequent Offering"), subject to approval by an Extraordinary General Meeting to be held on or about 11 April 2025. Date on which the terms and conditions of the subsequent offering/repair offering were announced: 11 March 2025; Last day including right: 10 March 2025; Ex-date: 11 March 2025; Record date: 12 March 2025; Date of approval: Expected to be on or about 11 April 2025 by resolution of an Extraordinary General Meeting (to be called); Maximum number of new shares: 600,000,000; and Subscription price: NOK 0.01.

Oslo, 11 March 2025 NOTE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN, HONG KONG OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.